MedTrace Logo

Post Market Clinical Study - Evolution® Esophageal Stent Systems, Europe: Fully and Partially Covered

NCT05182255 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 127

Last updated 2025-02-12

No results posted yet for this study

Summary

The aim of this post-market clinical follow-up study is to evaluate the continued safety and performance of the marketed Evolution® Esophageal Stent System (Partially- and Fully Covered).

Conditions

  • Esophageal Diseases

Interventions

DEVICE

Evolution® Esophageal Stent Systems, Europe: Fully and Partially Covered

To aid in maintaining patency of the esophagus in cases of obstruction of the esophagus caused by an esophageal disease and to seal tracheoesophageal fistula.

Sponsors & Collaborators

  • Cook Research Incorporated

    lead INDUSTRY

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-04-28
Primary Completion
2023-12-08
Completion
2023-12-08

Countries

  • Germany
  • Spain
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05182255 on ClinicalTrials.gov